EP2959900
Efnasamband til meðferðar á krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.6.2009EP published:
8.3.2017EP application number:
15168526.0
EP translation filed:
7.6.2017Grant published:
15.7.2017EPO information:
European Patent Register
Max expiry date:
15.6.2029Expiry date:
15.6.2026Next due date:
30.6.2026
Title:
COMPOUND FOR TREATMENT OF CANCER
Timeline
Today
16.6.2009EP application
8.3.2017EP Publication
7.6.2017Translation submitted
15.7.2017Registration published
15.6.2026Expires
Owner
Name:
University of Tennessee Research FoundationAddress:
211 Conference Center Building 600 Henley Street, 37996, Knoxville, TN, US
Name:
The Ohio State University Research FoundationAddress:
1216 Kinnear Road, 43212, Columbus, OH, US
Inventor
Name:
Miller, Duane, D.Address:
Collierville, TN, US
Name:
Wei, LiAddress:
Germantown, TN, US
Name:
Wang, ZhaoAddress:
Exton, PA, US
Name:
Lu, YanAddress:
Bartlett, TN , US
Name:
Chen, JianjunAddress:
Palos Hills, IL, US
Name:
Dalton, James, T.Address:
Ann Arbor, MI, US
Name:
Li, Chien-MingAddress:
Fremont, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
61875 PDate:
16.6.2008Country:
US
Classification
Categories:
A61K 31/4178, A61P 35/00, C07D 403/04
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 19.6.2017
Expires: 15.6.2018
Payer: Guðjón Styrkársson, hrl.
Number: 10
Paid: 14.5.2018
Expires: 15.6.2019
Payer: Árnason Faktor
Number: 11
Paid: 8.5.2019
Expires: 15.6.2020
Payer: Árnason Faktor
Number: 12
Paid: 5.5.2020
Expires: 15.6.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 11.5.2021
Expires: 15.6.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 6.5.2022
Expires: 15.6.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 24.5.2023
Expires: 15.6.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 7.5.2024
Expires: 15.6.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 2.6.2025
Expires: 15.6.2026
Payer: Árnason Faktor ehf.